CoChat

Toward a Diagnostic Score in Cushing's Syndrome

Open access
Braun, Leah T., Riester, Anna, Oßwald-Kopp, Andrea, Fazel, Julia, Rubinstein, German, Bidlingmaier, Martin, Beuschlein, Felix, Reincke, Martin · 2019 · Frontiers in Endocrinology
Cited by 81

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Cushing’s (CS) syndrome is a classical rare disease: it is often suspected in patients who do not have the disease, at the same time, it takes a mean of 3 years to diagnose CS in affected individuals. Main reason is the extreme rarity (1-3 / million / year) in combination with the lack of a single lead symptom. CS has to be suspected when a combination of signs and symptoms is present which together make up the characteristic phenotype of cortisol excess. Unusual fat distribution in face, neck and trunk, skin changes including plethora, acne, hirsutism, livid striae and easy bruising, signs of protein catabolism such as fragile skin, osteoporotic fractures and proximal myopathy indicate the need for biochemical screening for CS. In contrast, common symptoms like hypertension, weight gain or diabetes also occur quite frequently in the general population and per se do not justify confirmatory testing. First-line biochemical screening includes urinary free cortisol excretion, dexamethasone suppression testing and late-night salivary cortisol measurements. All 3 test have overall reasonable sensitivity and specificity, and first-line testing has to be selected on the basis of the physiologic conditions of the patient, drug intake and available laboratory quality control measures. Two normal test results usually exclude the presence of CS. Other tests and laboratory parameters like the high-dose-dexamethasone-suppression test, ACTH, the CRH-test and the bilateral inferior petrosal sinus sampling are not part of the first-line-screening. To avoid unnecessary diagnostic procedures, a general rule in endocrinology should also be applied to CS: First, it needs to be evaluated if the clinical appearance is suggestive for CS. Only if the pre-test-probability for CS is high, biochemical screening should be performed. This article provides an overview about the current standard in the diagnosis of CS starting with clinical scores and screenings, the clinical signs, relevant differential diagnoses, the first-line biochemical screening and ending with a few exceptional cases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fendo.2019.00766

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 81

Metadata

Authors
Braun, L. T., Riester, A., Oßwald-Kopp, A., Fazel, J., Rubinstein, G., Bidlingmaier, M., Beuschlein, F., & Reincke, M.
Venue
Frontiers in Endocrinology
Published
2019-11-08
Volume
10
Pages
766-766
ISSN
1664-2392 (ISSN-L)
OpenAlex
W2981747740
Cited by
81
References
40
FWCI
7.23
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toward a Diagnostic Score in Cushing's Syndrome. https://app.cochat.ai/papers/10.3389/fendo.2019.00766
The paper
Braun, L. T., Riester, A., Oßwald-Kopp, A., Fazel, J., Rubinstein, G., Bidlingmaier, M., Beuschlein, F., & Reincke, M. (2019). Toward a Diagnostic Score in Cushing's Syndrome. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2019.00766

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.